Meiji Yasuda Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.15M Sell
30,493
-210
-0.7% -$18.7K 0.14% 180
2026
Q1
$2.21M Buy
30,703
+824
+3% +$63.5K 0.11% 216
2025
Q4
$2.37M Buy
29,879
+1,203
+4% +$94.8K 0.11% 202
2025
Q3
$2.16M Buy
28,676
+14
+0% +$959 0.1% 200
2025
Q2
$1.98M Sell
28,662
-14,402
-33% -$944K 0.1% 208
2025
Q1
$2.92M Buy
43,064
+188
+0.4% +$11.3K 0.12% 194
2024
Q4
$1.92M Sell
42,876
-438
-1% -$24.6K 0.07% 231
2024
Q3
$2.72M Sell
43,314
-601
-1% -$35.1K 0.1% 202
2024
Q2
$2.59M Sell
43,915
-1,380
-3% -$86.3K 0.11% 191
2024
Q1
$3.61M Buy
45,295
+3,615
+9% +$276K 0.15% 159
2023
Q4
$3.29M Buy
41,680
+3,515
+9% +$250K 0.15% 179
2023
Q3
$2.66M Buy
38,165
+3,370
+10% +$239K 0.12% 212
2023
Q2
$2.4M Sell
34,795
-5,659
-14% -$403K 0.12% 194
2023
Q1
$3.01M Sell
40,454
-5,515
-12% -$462K 0.16% 173
2022
Q4
$4.28K Buy
45,969
+475
+1% +$45.8K 0.21% 144
2022
Q3
$4.34M Sell
45,494
-1,610
-3% -$159K 0.25% 121
2022
Q2
$4.37M Buy
47,104
+2,220
+5% +$217K 0.25% 118
2022
Q1
$4.54M Sell
44,884
-3,530
-7% -$371K 0.25% 121
2021
Q4
$4.99M Buy
48,414
+268
+0.6% +$24.8K 0.31% 89
2021
Q3
$4.09M Sell
48,146
-3,792
-7% -$318K 0.29% 95
2021
Q2
$4.33M Sell
51,938
-1,216
-2% -$99.6K 0.21% 102
2021
Q1
$4M Buy
53,154
+28,189
+113% +$2.05M 0.3% 90
2020
Q4
$1.71M Buy
24,965
+7,750
+45% +$504K 0.17% 147
2020
Q3
$1M Sell
17,215
-11,050
-39% -$688K 0.11% 180
2020
Q2
$1.84M Buy
28,265
+12,360
+78% +$778K 0.17% 140
2020
Q1
$944K Sell
15,905
-11,810
-43% -$788K 0.18% 110
2019
Q4
$2.06M Buy
27,715
+126
+0.5% +$8.85K 0.17% 155
2019
Q3
$1.74M Hold
27,589
0.14% 170
2019
Q2
$1.5M Sell
27,589
-26,416
-49% -$1.42M 0.13% 182
2019
Q1
$2.91M Sell
54,005
-4,450
-8% -$275K 0.25% 109
2018
Q4
$3.83M Buy
58,455
+24,868
+74% +$1.86M 0.36% 74
2018
Q3
$2.64M Sell
33,587
-3,690
-10% -$264K 0.22% 122
2018
Q2
$2.4M Buy
37,277
+800
+2% +$52.7K 0.21% 123
2018
Q1
$2.27M Buy
36,477
+450
+1% +$32.3K 0.22% 121
2017
Q4
$2.61M Sell
36,027
-1,130
-3% -$82.2K 0.25% 109
2017
Q3
$3.02M Sell
37,157
-1,430
-4% -$113K 0.3% 99
2017
Q2
$3.1M Sell
38,587
-90
-0.2% -$7.11K 0.32% 94
2017
Q1
$3.04M Sell
38,677
-540
-1% -$43.1K 0.32% 85
2016
Q4
$3.1M Sell
39,217
-530
-1% -$42.9K 0.35% 82
2016
Q3
$3.54M Buy
39,747
+6,240
+19% +$589K 0.41% 70
2016
Q2
$3.21M Buy
33,507
+10,020
+43% +$999K 0.46% 65
2016
Q1
$2.44M Buy
23,487
+150
+0.6% +$14.6K 0.55% 56
2015
Q4
$2.28M Sell
23,337
-610
-3% -$59.7K 0.52% 60
2015
Q3
$2.31M Buy
23,947
+390
+2% +$41K 0.57% 55
2015
Q2
$2.47M Buy
23,557
+800
+4% +$81.7K 0.58% 53
2015
Q1
$2.35M Sell
22,757
-540
-2% -$54.6K 0.57% 55
2014
Q4
$2.24M Sell
23,297
-2,170
-9% -$191K 0.54% 56
2014
Q3
$2.03M Buy
25,467
+300
+1% +$23.6K 0.48% 63
2014
Q2
$1.9M Buy
25,167
+1,520
+6% +$115K 0.39% 72
2014
Q1
$1.77M Sell
23,647
-2,410
-9% -$170K 0.38% 70
2013
Q4
$1.86M Sell
26,057
-1,063
-4% -$68.3K 0.39% 72
2013
Q3
$1.54M Sell
27,120
-222
-0.8% -$13.2K 0.35% 80
2013
Q2
$1.56M Buy
+27,342
New +$1.58M 0.37% 77

Other funds holding CVS

Meiji Yasuda Asset Management's CVS Position: Q2 2026 in Review

Meiji Yasuda Asset Management reduced its CVS Health (CVS) stake by 0.68% in Q2 2026, selling an estimated $18.7K and leaving 30,493 shares worth $3.15M. The position accounts for 0.14% of the portfolio, ranked #180.

Meiji Yasuda Asset Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.99M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Meiji Yasuda Asset Management held 30,493 shares of CVS Health worth $3.15M as of Q2 2026.
  • Meiji Yasuda Asset Management sold 210 CVS Health shares in Q2 2026, an estimated $18.7K.
  • CVS Health made up 0.14% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #180 holding.
  • Meiji Yasuda Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Meiji Yasuda Asset Management's CVS Health position peaked at $4.99M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.